Financial data tables

GSK (GSK) figures from its financial statements (company filings via Financial Modeling Prep), in US dollars; non-US reporters are converted to US dollars. Periods carry the company's own fiscal quarter and year, as its filings name them, with the date each period ended. Source filings are on the Filings tab.

GSK quarterly results
PeriodRevenueGross profitOperating incomeNet incomeDiluted EPSGross marginOperating margin
Q3 FY2026 (ended Sep 30, 2026)$11.11B$8.27B$3.21B$1.93B$0.9674.5%28.9%
Q2 FY2026 (ended Jun 30, 2026)$10.60B$7.74B$606.0M$548.0M$0.2873.0%5.7%
Q1 FY2026 (ended Mar 31, 2026)$9.61B$7.25B$2.89B$2.19B$1.0875.4%30.1%
Q4 FY2025 (ended Dec 31, 2025)$10.86B$7.51B$1.90B$801.0M$0.3969.2%17.5%
Q3 FY2025 (ended Sep 30, 2025)$10.77B$7.92B$3.27B$2.54B$1.2373.6%30.3%
Q2 FY2025 (ended Jun 30, 2025)$10.06B$7.33B$2.55B$1.82B$0.8872.9%25.3%
Q1 FY2025 (ended Mar 31, 2025)$9.47B$7.03B$2.79B$2.05B$0.9874.2%29.5%
Q4 FY2024 (ended Dec 31, 2024)$10.23B$7.00B$877.0M$522.0M$0.2568.5%8.6%
GSK quarterly cash flow
PeriodOperating cash flowCapital expendituresFree cash flowShare repurchasesDividends paid
Q3 FY2026 (ended Sep 30, 2026)$3.51B$469.0M$3.04B$2.0M$856.0M
Q2 FY2026 (ended Jun 30, 2026)$3.19B$414.0M$2.78B$389.0M$918.0M
Q1 FY2026 (ended Mar 31, 2026)$1.44B$558.0M$879.0M$411.0M$810.0M
Q4 FY2025 (ended Dec 31, 2025)$2.57B$706.0M$1.86B$0.0M$792.0M
Q3 FY2025 (ended Sep 30, 2025)$3.81B$540.0M$3.27B$565.0M$1.14B
Q2 FY2025 (ended Jun 30, 2025)$2.64B$798.0M$1.84B$707.0M$827.0M
Q1 FY2025 (ended Mar 31, 2025)$1.44B$564.0M$878.0M$311.0M$771.0M
Q4 FY2024 (ended Dec 31, 2024)$2.94B$1.43B$1.50B$0.0M$771.0M
GSK balance sheet
PeriodTotal assetsCash and equivalentsShort-term investmentsTotal debtTotal equity
Q3 FY2026 (ended Sep 30, 2026)$90.95B$3.72B$36.0M$30.06B$23.79B
Q2 FY2026 (ended Jun 30, 2026)$77.32B$3.89B$1.0M$22.84B$22.10B
Q1 FY2026 (ended Mar 31, 2026)$104.46B$5.72B$2.0M$31.66B$29.66B
Q4 FY2025 (ended Dec 31, 2025)$76.87B$4.27B$11.0M$22.29B$20.60B
GSK employees
YearEmployees
202594,066
202469,305
202370,244
202290,422
202190,096
202094,066

GSK (GSK) reported revenue of $11.11B in Q3 2026.

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites